quetiapine retard teva 200 mg tabl. verl. afgifte
teva pharma belgium sa-nv - quetiapinefumaraat 230 mg - eq. quetiapine 200 mg - tablet met verlengde afgifte - 200 mg - quetiapinefumaraat 230 mg - quetiapine
quetiapine retard teva 300 mg tabl. verl. afgifte
teva pharma belgium sa-nv - quetiapinefumaraat 345 mg - eq. quetiapine 300 mg - tablet met verlengde afgifte - 300 mg - quetiapinefumaraat 345 mg - quetiapine
quetiapine retard teva 400 mg tabl. verl. afgifte
teva pharma belgium sa-nv - quetiapinefumaraat 460 mg - eq. quetiapine 400 mg - tablet met verlengde afgifte - 400 mg - quetiapinefumaraat 460 mg - quetiapine
quetiapine retard teva 150 mg tabl. verl. afgifte
teva pharma belgium sa-nv - quetiapinefumaraat 172,5 mg - eq. quetiapine 150 mg - tablet met verlengde afgifte - 150 mg - quetiapinefumaraat 172.5 mg - quetiapine
quetiapine retard teva 150 mg tabl. verl. afgifte
teva pharma belgium sa-nv - quetiapinefumaraat 172,5 mg - eq. quetiapine 150 mg - tablet met verlengde afgifte - quetiapine
quetiapine retard teva 200 mg tabl. verl. afgifte
teva pharma belgium sa-nv - quetiapinefumaraat 230 mg - eq. quetiapine 200 mg - tablet met verlengde afgifte - quetiapine
quetiapine retard teva 300 mg tabl. verl. afgifte
teva pharma belgium sa-nv - quetiapinefumaraat 345 mg - eq. quetiapine 300 mg - tablet met verlengde afgifte - quetiapine
quetiapine retard teva 400 mg tabl. verl. afgifte
teva pharma belgium sa-nv - quetiapinefumaraat 460 mg - eq. quetiapine 400 mg - tablet met verlengde afgifte - quetiapine
quetiapine retard teva 50 mg tabl. verl. afgifte
teva pharma belgium sa-nv - quetiapinefumaraat 57,5 mg - eq. quetiapine 50 mg - tablet met verlengde afgifte - quetiapine
zoledronic acid teva pharma
teva b.v. - zoledroninezuur - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - geneesmiddelen voor de behandeling van botziekten - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. behandeling van de ziekte van paget van het bot bij volwassenen.